In Q4 2023, RTW Investments held 48 positions worth $5.6B. They initiated 8 new positions and exited 20. Their largest holding was RCKT ($530.3M). Portfolio value grew +36.0% versus the prior quarter.
Frequently asked questions
What stocks did RTW Investments own in Q4 2023?
RTW Investments held 48 biotech stocks in their 13F portfolio in Q4 2023. Their top positions include RCKT, IMCR, AXSM, ACAD, RARE. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was RTW Investments's portfolio worth in Q4 2023?
RTW Investments's tracked biotech portfolio was worth $5.6B across 48 positions, with total assets under management of approximately $10B. Portfolio values are based on 13F filings with the SEC.
What did RTW Investments buy in Q4 2023?
RTW Investments initiated 8 new positions in Q4 2023, including ARVN, AKRO, ETNB, SYRE, RDNT and 3 more. They also increased 11 existing positions.
What did RTW Investments sell in Q4 2023?
RTW Investments fully exited 20 positions in Q4 2023, including VKTX, SYK, SGMT, RLMD, PMVP and 15 more. They also trimmed 16 existing positions.
Is RTW Investments a biotech fund?
Data-driven biotech fund led by a physician-investor who combines clinical expertise with quantitative analysis. RTW takes concentrated positions across the biotech lifecycle, from crossover privates to public equities, with a focus on therapeutic areas where clinical data can be independently modeled.
Want AI analysis, insider signals, and catalyst overlays for RTW Investments?
View latest RTW Investments portfolio →